Your browser doesn't support javascript.
loading
Defining super-enhancers by highly ranked histone H4 multi-acetylation levels identifies transcription factors associated with glioblastoma stem-like properties.
Das, Nando D; Chang, Jen-Chien; Hon, Chung-Chau; Kelly, S Thomas; Ito, Shinsuke; Lizio, Marina; Kaczkowski, Bogumil; Watanabe, Hisami; Katsushima, Keisuke; Natsume, Atsushi; Koseki, Haruhiko; Kondo, Yutaka; Minoda, Aki; Umehara, Takashi.
Affiliation
  • Das ND; Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Chang JC; Laboratory for Cellular Epigenomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
  • Hon CC; Laboratory for Genome Information Analysis, RIKEN IMS, Yokohama, Japan.
  • Kelly ST; Laboratory for Cellular Epigenomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
  • Ito S; Laboratory of Developmental Genetics, RIKEN IMS, Yokohama, Japan.
  • Lizio M; Laboratory for Genome Information Analysis, RIKEN IMS, Yokohama, Japan.
  • Kaczkowski B; Laboratory for Applied Regulatory Genomics Network Analysis, RIKEN IMS, Yokohama, Japan.
  • Watanabe H; Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Katsushima K; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Natsume A; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Koseki H; Laboratory of Developmental Genetics, RIKEN IMS, Yokohama, Japan.
  • Kondo Y; Immune Regulation, Advanced Research Departments, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Minoda A; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Umehara T; Laboratory for Cellular Epigenomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
BMC Genomics ; 24(1): 574, 2023 Sep 27.
Article in En | MEDLINE | ID: mdl-37759202
ABSTRACT

BACKGROUND:

Super-enhancers (SEs), which activate genes involved in cell-type specificity, have mainly been defined as genomic regions with top-ranked enrichment(s) of histone H3 with acetylated K27 (H3K27ac) and/or transcription coactivator(s) including a bromodomain and extra-terminal domain (BET) family protein, BRD4. However, BRD4 preferentially binds to multi-acetylated histone H4, typically with acetylated K5 and K8 (H4K5acK8ac), leading us to hypothesize that SEs should be defined by high H4K5acK8ac enrichment at least as well as by that of H3K27ac.

RESULTS:

Here, we conducted genome-wide profiling of H4K5acK8ac and H3K27ac, BRD4 binding, and the transcriptome by using a BET inhibitor, JQ1, in three human glial cell lines. When SEs were defined as having the top ranks for H4K5acK8ac or H3K27ac signal, 43% of H4K5acK8ac-ranked SEs were distinct from H3K27ac-ranked SEs in a glioblastoma stem-like cell (GSC) line. CRISPR-Cas9-mediated deletion of the H4K5acK8ac-preferred SEs associated with MYCN and NFIC decreased the stem-like properties in GSCs.

CONCLUSIONS:

Collectively, our data highlights H4K5acK8ac's utility for identifying genes regulating cell-type specificity.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Glioblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Genomics Journal subject: GENETICA Year: 2023 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Glioblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Genomics Journal subject: GENETICA Year: 2023 Type: Article Affiliation country: Japan